MedTrace Logo

Effects of Bystander Model-Based Creative Drama on Empathy and Bullying Intervention in Middle School Students

NCT07098559 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-08-07

No results posted yet for this study

Summary

This research is a randomized controlled experimental study. The research aims to evaluate the effectiveness of creative drama workshops based on the bystander intervention model on middle school students' bystander intervention and empathy levels. The research population consists of sixth and seventh grade students. The research sample will consist of at least 42 middle school students, 21 in the intervention group and 21 in the control group. The sample will be selected through randomization. The students in the intervention group will receive 10 sessions of creative drama intervention. The research aims to answer the following questions: Is there a difference between the intervention group and the control group in terms of bystander intervention levels? Is there a difference between the intervention group and the control group in terms of empathy levels toward the victim of peer bullying?

Conditions

  • Bystander Intervention

Interventions

BEHAVIORAL

Creative drama

This intervention is unique in its integration of the Bystander Intervention Model with creative drama techniques to enhance empathy, self-efficacy, and active intervention behaviors among middle school students witnessing peer bullying. Unlike traditional anti-bullying programs that rely on lectures or cognitive-based approaches, this study uses experiential learning and role-playing scenarios to simulate real-life bullying situations and encourage emotional engagement and behavioral change.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-01-31
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07098559 on ClinicalTrials.gov